SEC Form 4 · accession 0001209191-17-053662
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerald Lema
Director
Period of report
Sep 19, 2017
Accepted (ET)
Sep 21, 2017 · 8:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $53.50 | Sep 19, 2017 | A | 12,000 | A | — | Sep 19, 2017 | Common Stock | 12,000 | 12,000 | D |
| Stock Option (Right to Buy)F2 | $53.50 | Sep 19, 2017 | A | 8,614 | A | — | Sep 19, 2017 | Common Stock | 8,614 | 8,614 | D |
Explanation of responses
- F1The shares subject to the option vest and become exercisable quarterly over three years measured from September 19, 2017.
- F2The shares subject to the option vest and become exercisable as follows: 2,614 shares on December 7, 2017; 3,000 on March 7, 2018; and 3,000 on June 7, 2018.